Market Cap | ₹146Cr |
ROE | 13.86% |
P/E Ratio(TTM) | 13.46 |
EPS(TTM) | 9.41 |
P/B Ratio | 1.75 |
Dividend Yield | 0.00% |
Industry P/E | 34.34 |
Book Value | 72.35 |
Debt to Equity | 0.84 |
Face Value | 10 |
Parent Organisation | Parnax Lab Limited |
Managing Director | Mr. Baiju Shah |
BSE Symbol | 506128 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 60.16 | ||
Ajanta Pharma | NA (0.00%) | 33.30 | ||
Gland Pharma | NA (0.00%) | 39.94 | ||
Eris Lifesciences | NA (0.00%) | 63.30 |